For the Inventor, By the Inventor

Enter inventor name

Kingsville, MD, United States of America

Barbara S Slusher

USPTO Granted Patents = 77 (Patent Applications = 15)

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 3.2

ph-index = 19

Forward Citations = 1,148(Granted Patents)

Inventors with similar research interests:

Location History:

Baltimore, MD (US) (2016 - 2023)
Kingsville, MD (US) (1997 - 2024)

Company Filing History:

Guilford Pharmaceuticals, Inc.

30 out of 3,682

The Johns Hopkins University

ÚStav Organické Chemie A Biochemie Av {Hacek Over (c)}r, V.v.i.

Institute of Organic Chemistry and Biochemistry Ascr, V.v.i.

Institute of Organic Chemistry & Biochemistry

6. 1 out of 269

Icahn School of Medicine at Mount Sinai

Inst of Organic Chem. and Biochemistry As Cr V.v.i

ÚStav Organické Chemie A Biochemie Av {Hacek Over (c)}{hacek Over ( )}R, V.v.i.

Eisai Corporation of North America

10. 1 out of 27

Ustav Organicke Chemie a Biochemie Av Cr, V.v.i.

11. 1 out of 33

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

Loading Chart...

Loading Chart...

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195450 - Small molecule neutral sphingomyelinase 2 (nSMase2) inhibitors (2025-01-14),

2. 12195419 - Glutamine antagonists and uses thereof (2025-01-14),

3. 11932664 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2024-03-19),

4. 11926640 - Prodrugs of glutamine analogs (2024-03-12),

5. 11866394 - Prodrugs of hydroxamate-based GCPII inhibitors (2024-01-09),

6. 11766423 - 2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases (2023-09-26),

7. 11759466 - Inhibition of nSMase for the treatment of human immunodeficiency virus infection (2023-09-19),

8. 11759444 - Methods for cancer and immunotherapy using prodrugs of glutamine analogs (2023-09-19),

9. 11712435 - Mebendazole prodrugs with enhanced solubility and oral bioavailability (2023-08-01),

10. 11427590 - Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases (2022-08-30),

11. 11331271 - Buccal, sublingual and intranasal delivery of fospropofol (2022-05-17),

12. 11325931 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2022-05-10),

13. 11191732 - Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy (2021-12-07),

14. 11185534 - Prodrugs of glutamine analogs (2021-11-30),

15. 11110104 - Glutamine antagonists for the treatment of cognitive deficits and psychiatric disorders (2021-09-07),

Title: The Innovative Journey of Barbara S. Slusher

Introduction: Barbara S. Slusher, a pioneering inventor hailing from Kingsville, MD, has made significant contributions to the field of innovations and inventions, particularly in the realm of healthcare and pharmaceuticals.

Latest Patents: Barbara S. Slusher holds several patents in the medical field, focusing on novel drug delivery systems and innovative treatment methods for various diseases and conditions.

Career Highlights: With a distinguished career spanning over two decades, Barbara S. Slusher has worked tirelessly to develop groundbreaking solutions that have the potential to revolutionize the healthcare industry. Her innovative approach to drug development has garnered recognition and praise from peers and experts alike.

Collaborations: Throughout her career, Barbara S. Slusher has collaborated with leading researchers, scientists, and medical professionals to bring her inventions to life. Her ability to work effectively in multidisciplinary teams has been instrumental in the success of her projects.

Conclusion: Barbara S. Slusher's unwavering dedication to innovation and her passion for improving healthcare outcomes have solidified her position as a trailblazer in the field of inventions. Her work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of healthcare innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…